Safety Alerts Saves Lives
Safety Alerts  
Home Privacy About Us Contact Us Change Preferences

November 7, 2000

Danbury Pharmacal of Puerto Rico Recalls Doxycycline Hyclate Capsules

Humacao, Puerto Rico (SafetyAlerts) - The Food and Drug Administration (FDA) said today that Danbury Pharmacal of Puerto Rico, Inc. is recalling certain Doxycycline Hyclate Capsules because the product exceeds USP limit for water content.

This is the first public notice of this Class III issued by FDA.

a) Doxycycline Hyclate Capsules, USP, 50 mg, in bottles of 50, NDC #0364-2023-50;
b) Doxycycline Hyclate Capsules, 100 mg, in bottles of 50 and 500, NDC #0364-2033-05, Schein Pharmaceutical label.

Recall #D-008/009-1.

Lot Numbers: P9H0299 EXP AUG 01 and P9E0179 EXP MAY 01.

Danbury Pharmacal of Puerto Rico, Inc., Subsidiary of Schein Pharmaeutical, Inc., Humacao, Puerto Rico.

Manufacturer, by mail on August 16, 2000. Firm-initiated recall ongoing.

Nationwide and international.

7,590 bottles of 50 (lot P9H0299); 28,205 bottles of 50 (lot P9E0179) and 2,888 bottles of 500 (lot P9E0179) were distributed.

Questions concerning this recall may be directed to the FDA at 1-888-INFO-FDA.

Selected Recent Recalls

Health Professional:

Did you know?
During 2000 there were over
1050 products recalled in the United
States for safety reasons!

How many did you hear about?

Sign-up for SafetyAlerts by Email -
The free internet newsletter that could
some day literally save your life - or
the life of someone you know.

Safety Alerts compiles comprehensive safety recall information for the United States. SafeMail is a free email service to warn consumers of faulty products and contaminated foods. For complete information regarding current recalls, past recalls and timely product warning notification visit:



The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.